NEUROTECH INTERNATIONAL LIMITED - Announcements

0.00%

1.3¢

Market Cap $13.64M

Healthcare Biotechnology

Neurotech International Limited is an Australia-based clinical-stage biopharmaceutical... Neurotech International Limited is an Australia-based clinical-stage biopharmaceutical development company. The Company is focused predominately on pediatric neurological disorders with a broad-spectrum oral cannabinoid drug therapy called NTI164. It has completed a Phase II/III randomized, double-blind, placebo-controlled clinical trial in autism spectrum disorder (ASD) with clinically significant benefits reported across a number of clinically validated measures and safety. In addition, it has completed and reported significant and clinically meaningful Phase I/II trials in ASD and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) and pediatric acute-onset neuropsychiatric syndrome (PANS), collectively PANDAS/PANS along with Rett Syndrome. NTI164 is being developed as a therapeutic drug product for a range of neurological disorders in children where neuroinflammation is involved.More

HELPING PATIENTS ON THEIR JOURNEY TO BETTER HEALTH

Little Green Pharma (ASX:LGP) to benefit as Denmark commits to cannabis pilot program.

Announcements

Filter Results

All Price Sensitive Only

NTI	Half Year Report and Accounts	PRICE SENSITIVE	01/03/17	1.2MB	Share
NTI	Emergo Appointment		06/02/17	499.48KB	Share
NTI	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/17	281.51KB	Share
NTI	Company Update		31/01/17	531.39KB	Share
NTI	Mente Autism Shipment	PRICE SENSITIVE	22/12/16	488.44KB	Share
NTI	Scientific Advisory Board		20/12/16	523.21KB	Share
NTI	AGM Results		29/11/16	211.62KB	Share
NTI	Investor Presentation		28/11/16	2.79MB	Share
NTI	Notice of Meeting		15/11/16	440.2KB	Share
NTI	Launch of Mente Autism	PRICE SENSITIVE	11/11/16	289.14KB	Share
NTI	Neurotech Commences Trade on ASX		04/11/16	367.53KB	Share
NTI	Becoming a substantial holder		04/11/16	56.25KB	Share
NTI	Becoming a substantial holder		04/11/16	787.69KB	Share
NTI	Initial Director's Interest Notice		04/11/16	336.54KB	Share
NTI	Initial Director's Interest Notice		04/11/16	229.68KB	Share
NTI	Initial Director's Interest Notice		04/11/16	234.18KB	Share
NTI	Initial Director's Interest Notice		04/11/16	227.87KB	Share
NTI	Initial Director's Interest Notice		04/11/16	222.38KB	Share
NTI	Initial Director's Interest Notice		04/11/16	222.07KB	Share
NTI	Becoming a substantial holder		04/11/16	72.42KB	Share
NTI	Additional Confirmation Statements		03/11/16	292.03KB	Share
NTI	Terms of Options		03/11/16	69.62KB	Share
NTI	Restricted Securities Statement		03/11/16	208.84KB	Share
NTI	Security Trading Policy		03/11/16	103.15KB	Share
NTI	Financial Accounts		03/11/16	13.61MB	Share
NTI	Constitution		03/11/16	3.02MB	Share
NTI	Prospectus		03/11/16	4.19MB	Share
NTI	Top 20 holders		03/11/16	52.18KB	Share
NTI	Distribution Schedule		03/11/16	86.85KB	Share
NTI	Appendix 1A and Information Form and Checklist		03/11/16	318.82KB	Share
NTI	Pre-Quotation Disclosure		03/11/16	91.32KB	Share
NTI	ASX Notice		03/11/16	90.37KB	Share
NTI	Admission to Official List	PRICE SENSITIVE	03/11/16	80.8KB	Share

NTI Half Year Report and Accounts
01/03/17	PRICE SENSITIVE	1.2MB	Share
NTI Emergo Appointment
06/02/17		499.48KB	Share
NTI Appendix 4C - quarterly
31/01/17	PRICE SENSITIVE	281.51KB	Share
NTI Company Update
31/01/17		531.39KB	Share
NTI Mente Autism Shipment
22/12/16	PRICE SENSITIVE	488.44KB	Share
NTI Scientific Advisory Board
20/12/16		523.21KB	Share
NTI AGM Results
29/11/16		211.62KB	Share
NTI Investor Presentation
28/11/16		2.79MB	Share
NTI Notice of Meeting
15/11/16		440.2KB	Share
NTI Launch of Mente Autism
11/11/16	PRICE SENSITIVE	289.14KB	Share
NTI Neurotech Commences Trade on ASX
04/11/16		367.53KB	Share
NTI Becoming a substantial holder
04/11/16		56.25KB	Share
NTI Becoming a substantial holder
04/11/16		787.69KB	Share
NTI Initial Director's Interest Notice
04/11/16		336.54KB	Share
NTI Initial Director's Interest Notice
04/11/16		229.68KB	Share
NTI Initial Director's Interest Notice
04/11/16		234.18KB	Share
NTI Initial Director's Interest Notice
04/11/16		227.87KB	Share
NTI Initial Director's Interest Notice
04/11/16		222.38KB	Share
NTI Initial Director's Interest Notice
04/11/16		222.07KB	Share
NTI Becoming a substantial holder
04/11/16		72.42KB	Share
NTI Additional Confirmation Statements
03/11/16		292.03KB	Share
NTI Terms of Options
03/11/16		69.62KB	Share
NTI Restricted Securities Statement
03/11/16		208.84KB	Share
NTI Security Trading Policy
03/11/16		103.15KB	Share
NTI Financial Accounts
03/11/16		13.61MB	Share
NTI Constitution
03/11/16		3.02MB	Share
NTI Prospectus
03/11/16		4.19MB	Share
NTI Top 20 holders
03/11/16		52.18KB	Share
NTI Distribution Schedule
03/11/16		86.85KB	Share
NTI Appendix 1A and Information Form and Checklist
03/11/16		318.82KB	Share
NTI Pre-Quotation Disclosure
03/11/16		91.32KB	Share
NTI ASX Notice
03/11/16		90.37KB	Share
NTI Admission to Official List
03/11/16	PRICE SENSITIVE	80.8KB	Share

REFRESH

First 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 1.3¢		Change 0.000(0.00%)		Mkt cap ! $13.64M

Open	High	Low	Value	Volume
1.3¢	1.3¢	1.3¢	$35.66K	2.743M

Buyers (Bids)

No.	Vol.	Price($)
13	2868143	1.2¢

Sellers (Offers)

Price($)	Vol.	No.
1.3¢	245522	1

View Market Depth

No.	Vol.	Price($)
13	2868143	0.012
8	2118288	0.011
7	2070000	0.010
1	100000	0.009
4	969000	0.008

Price($)	Vol.	No.
0.013	245522	1
0.014	1798134	5
0.015	365204	4
0.016	495817	6
0.017	362563	3

Last trade - 14.27pm 05/09/2025 (20 minute delay)


Last 1.3¢		Change 0.000 ( 0.00 %)
Open	High	Low	Volume
1.3¢	1.3¢	1.3¢	341195
Last updated 14.54pm 05/09/2025 ?

NTI (ASX) Chart

NEUROTECH INTERNATIONAL LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories